List of PHC Group Executive and Leadership Team

Leadership Overview

PHC Group has 4 executives leading key functions including strategy, finance, and operations.

Driven by innovation, PHC Group is dedicated to advancing global healthcare through specialized diagnostic services and comprehensive medical solutions, impacting both business and consumer markets with cutting-edge technologies.

Leadership Roles at PHC Group

Chief Executive Officer - Kay Deguchi

President & Representative & Director & Chief Executive Officer - Kyoko Deguchi

Executive Corporate Officer and Chief Financial Officer - Kaiju Yamaguchi

Chief Operating Officer & Head of Diabetes Management Business - Koichiro Sato

Kay Deguchi - Chief Executive Officer

Kay Deguchi, the Chief Executive Officer at PHC Group, directs the overarching strategy and global vision for the company's diagnostic services and healthcare solutions. This leadership role involves guiding PHC Group's expansion across Asia, Europe, and North America, ensuring innovative healthcare technologies are delivered through mobile applications and digital platforms. Deguchi oversees the integration of business and consumer market strategies, focusing on the delivery of comprehensive diagnostic tools and medical health solutions. The Chief Executive Officer's responsibilities include fostering a culture of innovation and driving the company's commitment to improving healthcare outcomes worldwide. Kay Deguchi's strategic direction ensures PHC Group remains at the forefront of the healthcare technology sector, adapting to evolving market demands and technological advancements to maintain a competitive edge.

Kyoko Deguchi - President & Representative & Director & Chief Executive Officer

Kyoko Deguchi, the President & Representative & Director & Chief Executive Officer at PHC Group, executes critical operational directives and represents the company's interests at the highest levels. This multifaceted role involves ensuring seamless coordination across all business units and geographical regions, including Asia, Europe, and North America. The President & Representative & Director & Chief Executive Officer champions the company's mission to provide advanced diagnostic services and healthcare solutions, driving the adoption of innovative technologies. Kyoko Deguchi's leadership focuses on strengthening the company's market position by optimizing the delivery of medical diagnostic products and services to healthcare facilities globally. This executive's oversight ensures adherence to stringent quality standards and regulatory compliance, vital for maintaining trust and credibility in the healthcare sector.

Kaiju Yamaguchi - Executive Corporate Officer and Chief Financial Officer

Kaiju Yamaguchi, the Executive Corporate Officer and Chief Financial Officer at PHC Group, manages all financial operations and fiscal strategy for the global healthcare company. This critical position involves overseeing financial planning, budgeting, and investment strategies to support PHC Group's expansion in diagnostic services and healthcare solutions across Asia, Europe, and North America. The Executive Corporate Officer and Chief Financial Officer ensures robust financial health, enabling the development and deployment of innovative healthcare technologies through digital platforms. Kaiju Yamaguchi's responsibilities include managing capital allocation, optimizing resource utilization, and ensuring compliance with international financial regulations. This leadership ensures the company's financial stability and capacity to invest in future growth and technological advancements, directly supporting the delivery of medical diagnostic products and services worldwide.

Koichiro Sato - Chief Operating Officer & Head of Diabetes Management Business

Koichiro Sato, the Chief Operating Officer & Head of Diabetes Management Business at PHC Group, directs the operational execution of the company's global healthcare solutions, with a specific focus on the diabetes management sector. This role involves optimizing the supply chain, manufacturing processes, and service delivery for diagnostic products and technologies across Asia, Europe, and North America. The Chief Operating Officer & Head of Diabetes Management Business ensures that PHC Group's innovative healthcare technologies, including mobile applications and digital platforms, are efficiently deployed to meet market demands. Koichiro Sato's leadership drives operational excellence, enhancing the company's ability to serve both business and consumer markets with comprehensive diagnostic tools. This executive's focus on the diabetes management business segment is crucial for expanding market share and reinforcing PHC Group's commitment to improving health outcomes in this key area.

Explore Leadership Teams in Manufacturing

LifeNet Health

LifeNet Health is a nonprofit organization dedicated to advancing the field of regenerative medicine through innovative transplantation and cellular solutions. The organization provides comprehensive tissue and organ donation services while supporting healthcare providers, researchers, and patients worldwide. By combining cutting-edge medical technology with rigorous quality standards, LifeNet Health enables life-saving procedures and regenerative therapies that enhance patient outcomes and improve quality of life.

Company Leadership

Miracle-Ear

Miracle-Ear, a division of Amplifon Group, has been a trusted resource in hearing solutions for over 70 years. Based in Minneapolis, MN, Miracle-Ear specializes in customizable hearing solutions that feature discreet, comfortable products designed to meet each individual's hearing loss needs.

Company Leadership

Advita

Advita Ortho, headquartered in Gainesville, Florida, is a global medical device company dedicated to advancing patient lives through innovative orthopedic solutions. Officially launched in November 2025, the company delivers high-quality orthopedic implants and a comprehensive suite of integrated surgical technologies powered by data, artificial intelligence, and machine learning. Advita Ortho owns and distributes established product lines including the Equinoxe Shoulder, Vantage Ankle, Alteon Hip, Truliant Knee, Newton balancing technology, and GPS navigation systems, among others. The company's portfolio creates an ecosystem designed to enhance surgical decision-making in the operating room while driving efficiency for healthcare systems. Led by industry veterans and backed by investment firms including Strategic Value Partners, Stellex Capital Management, and Greywolf Capital Management, Advita Ortho positions itself as a trusted partner to orthopedic surgeons worldwide, providing tools and technologies designed to improve patient outcomes and quality of life.

Company Leadership

MiMedx Group

MiMedx Group, Inc., a biopharmaceutical company, develops and markets regenerative biologics utilizing human placental tissue allografts with patent-protected processes for various sectors of healthcare. It processes the human placental tissue utilizing its proprietary PURION Process to produce allografts. The companys proprietary processing methodology employs aseptic processing techniques in addition to terminal sterilization. Its biomaterial platform technologies include AmnioFix and EpiFix that are tissue technologies processed from human amniotic membrane derived from donated placental tissue for homologous applications; OrthoFlo, an amniotic fluid-derived allograft for homologous applications; Physio, a bone grafting material comprising 100% bone tissue with no added carrier; and CollaFix, a technology platform derived from collagen fiber technology designed to mimic the natural composition, structure, and mechanical properties of musculoskeletal tissues to augment their repair. The company also offers EpiCord, an umbilical cord allograft that provides a connective tissue matrix to replace or supplement damaged or inadequate integumental tissue; AmnioCord, an umbilical cord allograft that offers a protective environment for the healing process; and AmnioFill, a cellular tissue matrix allograft that enhances healing. Its products have applications in the areas of wound care, burns, surgery, orthopedics, spine, sports medicine, ophthalmology, and dentistry. The company sells its products through direct sales force, and independent stocking distributors, and third party representatives in the United States, as well as independent distributors internationally. MiMedx Group, Inc. is headquartered in Marietta,...

Company Leadership

Frequently Asked Questions Regarding PHC Group Top Executives and Leadership Team

Who leads PHC Group?

PHC Group is led by Kay Deguchi (Chief Executive Officer), along with executives such as Kyoko Deguchi (President & Representative & Director & Chief Executive Officer) and Kaiju Yamaguchi (Executive Corporate Officer and Chief Financial Officer).

Who is part of PHC Group’s executive team?

The executive team of PHC Group includes leaders such as Kay Deguchi (Chief Executive Officer), Kyoko Deguchi (President & Representative & Director & Chief Executive Officer), Kaiju Yamaguchi (Executive Corporate Officer and Chief Financial Officer) and other senior executives.

How many executives does PHC Group have?

PHC Group has 4 executives leading key business areas.

What roles are included in PHC Group’s leadership team?

The leadership team of PHC Group includes roles such as Chief Executive Officer, President & Representative & Director & Chief Executive Officer, Executive Corporate Officer and Chief Financial Officer, Chief Operating Officer & Head of Diabetes Management Business.